Lupin has received ‘A-’ leadership rating from CDP for its outstanding performance in climate change and water security. This rating reflects Lupin's leadership in environmental transparency and performance and underscores the strategic and systematic efforts in its sustainability journey.
CDP is a global non-profit that runs the world’s only independent environmental disclosure system for companies to manage their environmental impact. As the founder of environmental reporting, CDP believes in transparency and the power of data to drive change.
Lupin's sustainability framework is integral to its business operations, prioritizing environmental stewardship, employee well-being, supply chain sustainability, and patient-centric innovation. By integrating these principles, Lupin is paving the way for a sustainable and equitable future. The 2024 CDP scores of ‘A-' with regard to Climate and Water, mark a significant development from last year's ‘B’ rating in Climate, and ‘C’ rating in Water.
Lupin has demonstrated significant progress in reducing its carbon footprint through various initiatives. Earlier this year, Lupin’s S&P Global ESG scores moved to 76 from 69 last year, above the industry average of 30 in the pharmaceuticals sector.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
